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with surgical bypass, with shorter hospitalizations in symptomatic and
asymptomatic patients. Further long-term follow-up is required to compare
these two treatment modalities for durability to determine the optimal
popliteal aneurysm management.
Multifactorial Disease Severity Score (DSS) Predicting the Success of
Endovascular Intervention of Femoropopliteal Peripheral Arterial
Disease
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James F. McKinsey, MD1. 1Columbia University, New York Presbyterian
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Objective(s): The goal was to create a multifactorial Disease Severity
Score (DSS) for characterization of femoropopliteal arterial lesions. By
having a greater understanding of the effect of patient comorbidities and an
in-depth method to characterize an arterial lesion, we may be able to better
compare lesions in different studies and predict which therapy is most
appropriate for each lesion undergoing an endovascular intervention (EVI).
Methods: We evaluated 44 lesion and patient characteristics in our
prospectively maintained lower extremity arterial lesion database from 2005
to 2009 to create a gradated DSS.
Results: We identified 1329 femoropopliteal lesions in 675 patients.
Statistical analysis by multivariable Cox proportional hazards model identi-
fied 16 variables that impact patency: seven lesion characteristics (Table I)
and nine patient characteristics or comorbidities (Table II). Factors with the
most impact were a chronic total occlusion (DSS 16), lesion length 100
mm (DSS 13), and no runoff vessels and stenosis of 80% to 99% (DSS 9).
The following factors were considered baseline, or score of 0: stenosis80%,
lesion length 100 mm, and three-vessel runoff. By adding these variable
scores, a DSS was created and used to predict patency of the EVI.
Conclusions: The presence of a chronic total occlusion, lesion
length 100 mm, poor runoff, and the presence of congestive heart
failure have the most dramatic effect on patency after EVI. A compre-
hensive DSS allows for the in-depth classification of lesion characteristics
and factors that predict success of EVI and can allow for comparison of
distinct lesions. Future comparisons of effectiveness of treatment modal-
ities can be possible.
Table I. Significant femoropopliteal lesion characteristics that negatively
impact patency after endovascular intervention
Factor Score HR (95% CI)
Chronic total occlusion 16 1.73 (1.28-2.33)
Stenosis 80%-90% 9 1.38 (1.06-1.78
Lesion length 100 mm 13 1.55 (1.25-1.93)
Vessel runoff
0 9 1.36 (0.95-1.96)
1 7 1.29 (0.96-1.73)
2 1 1.04 (0.77-1.40)
Lesion calcification 1 1.04 (0.82-1.31)
CI, Confidence interval; HR, hazard ratio.
Table II. Patient characteristics that impact patency after endovascular
intervention
Factor (N  16) Score Cox coefficient HR (95% CI)
CHF 8 0.274 1.32 (0.99-1.74)
Female sex 7 0.227 1.25 (0.96-1.63)
Current smoker 7 0.234 1.26 (0.80-1.99)
Former smoker 3 0.121 1.13 (0.85-1.50)
Diabetes 6 0.199 1.22 (0.94-1.58)
CAD 4 0.147 1.16 (0.88-1.53)
Renal 4 0.140 1.15 (0.85-1.55)
Age, years
50-64 6 0.195 1.22 (0.84-1.76)
65-79 2 0.075 0.93 (0.69-1.25)
CAD, Coronary artery disease; CHF, congestive heart failure; CI, confi-
dence interval; HR, hazard ratio.
Defining the Role of Endovascular Therapy in Critical Limb Ischemia
With Tissue Loss
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Objective(s): We compare the utility of endovascular therapy (ET)
with bypass surgery for critical limb ischemia (CLI) with tissue loss and
identify risk factors for failure of ET.
Table.
Hazard
ratio (HR/
AOR)
95% CI for HR/
AOR P value
Overall survival
Dialysis dependence 3.0 1.1–81. .03
Angina 5.1 1.3–20.3 .02
COPD 3.8 1.8–8.3 .001
Amputation free survival
Rutherford 6 3.6 1.4–9.2 .007
COPD 3.6 1.3–9.6 .01
Limb salvage
Rutherford 6 35.1 5.4–231 .0001
Wound healing at 12 months
Diabetes 7.0 1.4–36 .02
Current smoking 5.3 1.1–26 .04
Patency loss 4.8 1.1–22 .04
Methods: A retrospective review (2004 to 2010) of patients under-
going ET for tissue loss (Rutherford class 5 and 6) provided data for
multivariate models of overall survival, amputation-free survival (AFS),
limb salvage, and wound healing. Comparisons were made with a bypass
surgery cohort matched for tissue loss.
Results: Ninety-four patients underwent ET (58% TransAtlantic
InterSociety Concensus [TASC] C/D; 44% tibial) for Rutherford 5
(88%) or Rutherford 6 (12%) CLI with tissue loss of the heel (15%),
forefoot (16%), toe(s) (43%), calf/ankle (11%), or multiple locations
(15%). Sustained limb salvage was 83%  5%. Overall survival was 44% 
7% and AFS was 40% 7% at 2 years. Predictors of failure by multivariate
models are reported in the Table. Comparison between the Rutherford 5
WRsubgroup (n  83) and an Rutherford 5 bypass cohort (n  66),
suggest equivalent limb salvage, with reduced AFS (P  .04) and a trend
toward reduced overall survival (P  .09). Early would healing was
higher after bypass: 43% vs 11% at 3 months (P  .001) and 57% vs 30%
at 6 months (P  .01).
Conclusions: Given the short life expectancy of patients with tissue
loss, ET permits sustained limb salvage in patients at high risk for bypass
(particularly Rutherford 5). However, wound healing is slow compared
with bypass and requires sustained patency.
Midterm Results of Limb Salvage and Stent Patency with Popliteal
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Objective(s): This study evaluated the relationship of stent location on
limb salvage and stent patency in patients undergoing popliteal artery
stenting.
Methods: We performed a retrospective review of a prospectively
collected database, identifying all patients undergoing popliteal artery
stenting between September 2009 and February 2012. Patients were
divided into two groups based on the position of the distal end of the
stent in relation to the knee joint. The proximal popliteal stent group
included patients receiving a stent ending above the patella (above the
flexion point of the knee). The distal popliteal stent group included
patients receiving a stent(s) ending below the patella (in the flexion
zone). Data collected included demographics, indication for surgery,
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intraoperative findings, and follow-up duration. The outcomes studied
were limb salvage and primary stent patency. Continuous data were
analyzed with a t test, and categoric data were analyzed with a 2 test.
Results: We identified 40 patients in the proximal stent group and
56 in the distal stent group. Follow-up imaging data were available for 82
patients. The two groups did not differ in demographics, mean number
of patent runoff vessels (proximal, 2.0 vessels; distal, 1.8 vessels; P 
.18), or mean duration of follow-up (proximal, 259 days; distal, 257
days; P  .98). Claudication was more often an indication for popliteal
stent placement in the proximal group (42% vs 16%; P  .004). Limb-
threatening ischemia was more frequently an indication for stent place-
ment in the distal group (75% vs 55%; P  .04). Limb salvage was
achieved in 92.5% of proximal and in 85.7% of distal stent placements
(P  .30). Limb salvage did not differ between the groups when only
patients with limb-threatening ischemia were included in the analysis
(proximal, 86%; distal, 83%; P  .75). Primary patency at 3 months was
57% in the proximal group vs 49% in the distal group (P  .46).
Conclusions: Popliteal artery stenting is associated with a high rate
of limb salvage at a mean follow-up of 8 months and is an acceptable
option for patients with incapacitating claudication and limb-threatening
ischemia who are poor candidates for alternative interventions. Popliteal
stents placed across the knee joint did not affect limb salvage or patency
compared with stents placed above the knee joint.
Low Levels of High-Density Lipoproteins Are Associated With Acute
Kidney Injury Following Revascularization for Chronic Limb Ischemia
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Objective(s): Perioperative acute kidney injury (AKI) is not uncom-
mon in patients after extremity revascularization. High-density lipopro-
teins (HDL) have been shown to reduce organ injury and death in animal
models via modulation of adhesion molecules and cytokines. Our aim was
to examine the association of HDL and other factors on perioperative
AKI in patients undergoing revascularization for symptomatic chronic
limb ischemia.
Methods: All patients who underwent open or endovascular revas-
cularization between June 2001 and December 2009 for symptomatic
chronic limb ischemia (Rutherford category 3 to 6) were retrospectively
analyzed. Patients on dialysis and those with incomplete data were
excluded. Patients were grouped for HDL 40 or 40 mg/dL. Univar-
iate and multivariate analysis were used to identify factors associated with
AKI.
Results: Included were 684 patients (219 open, 465 endovascular/
hybrid) with diabetes (47%) chronic kidney disease (20%), critical limb
ischemia (31%), and 40 HDL (60%). Medications included statin use
(57%), angiotensin converting enzyme inhibitors/angiotensin receptor
blockers (53%). Postoperative AKI developed in 85 patients (12.4%),
9.4% endovascular vs 12.6% open (P  NS). The AKI group was more
likely to be older (71.5  10.1 vs 68.0  10.8 years, P  .01), have
diabetes (60% vs 46%, P .01), be using angiotensin-converting enzyme
inhibitors/angiotensin receptor blockers (64% vs 52%, P  .04), and
have pre-existing chronic kidney disease (36% vs 17%, P  .001). AKI
occurred in 16% of patients with low HDL and in 7% with high HDL
(P  .001). Multivariate analysis using logistic and propensity score
showed that HDL level (hazard ratio, 2.4; 95% confidence interval,
1.4-4.2) and underlying chronic kidney disease were independent pre-
dictors of postoperative AKI (P  .001).
Conclusions: AKI after revascularization is not uncommon (12.4%),
and lower HDL, along with chronic kidney disease, is associated with
increased odds of postoperative AKI. If these observations can be verified
in a prospective fashion, strategies for increasing HDL level in patients
with a high risk of postoperative AKI should be investigated.
Reduction in Hospital Length of Stay for Patients Requiring Lower
Extremity Amputation
Joshua Unger, MD, Daniel Geersen, PAC, Nancy Payne, RN, Lu-Anne
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Objective(s): This study evaluated the effect of a multidisciplinary
approach and initiation of care pathways on hospital length of stay (LOS) for
lower extremity amputations.
Methods: Patients undergoing lower extremity amputations (toe,
below the knee, above the knee, or revision of prior amputation) between
January 2010 and December 2011 were retrospectively identified by
International Classification of Diseases–9th Edition codes (84.11, 84.12,
84.14, 84.15, or 84.3) in our institution’s administrative database after
obtaining Investigational Review Board approval. Midway through the
study period, in January 2011, a multidisciplinary change in care of these
patients was initiated. Among the changes made was initiation of twice-
weekly rounds with representatives from vascular surgery, limb loss
counseling, physical therapy, and a discharge coordinator. Patients’
discharge diagnoses and medical comorbidities were analyzed by All
Patient Refined Diagnosis Related Group (APR-DRG) in the University
HealthSystem Consortium (UHC) Clinical Database. LOS before and
after the change in practice was compared with similar patients in
academic institutions nationwide via the LOS index, defined as actual
LOS-to-expected LOS ratio.
Results: During the 2-year study period, 150 patients underwent 188
amputations, including 114 amputations in 2010. After the change in practice, 74
amputationswere performed in 2011. Patient demographicswere consistent across
the study period, including a72%prevalence of diabetesmellitus. AverageLOSwas
11.17.04days in 2010 anddecreased to9.616.37days in 2011 (P .0621),
without a significant change in readmission rate. The crude LOS decrease was not
statistically significant, but when adjusted for patient comorbidities, the LOS index
was significantly decreased from 1.19 0.629 in 2010 to 1.03 0.547 in 2011
(P .0365). LOS indexwas inversely related to the 30-day readmission rate (Fig).
Total savings to the hospital$150,000 for 2011.
Conclusions: A multidisciplinary partnership of physician and hos-
pital team members resulted in a decrease in LOS of 1.5 days for patients
undergoing lower extremity amputations, representing increased effi-
ciency of care and decreased observed costs.
Association of Inflammatory and Metabolic Serum Biomarkers With
Carotid Intima Media Thickness (cIMT) in a Community-Based Pop-
ulation: The Heart Strategies Concentrating on Risk Evaluation
(Heart SCORE) Study
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Reis1. 1University of Pittsburgh Medical Center, Pittsburgh, Pa, and 2Uni-
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Objective(s):Carotid intimamedia thickness (cIMT) has been broadly
used as a surrogate measure for cardiovascular risk but is not widely available
or standardized. Our goal was to identify a set of serum biomarkers associ-
ated with cIMT independent of race and sex.
Methods: The Heart Strategies Concentrating on Risk Evaluation
(SCORE) study is a prospective community-based cohort study of 2000
adults that started enrollment in 2003. Serum biomarkers of inflammation,
metabolic, and endothelial function were obtained and examined in relation
to cIMT, which wasmeasured as a continuous variable and categorically with
a cutoff of 1 mm.
Results: cMIT was measured in 697 patients (66% white, 32% black;
62% women). Cohort demographics and comorbidities are detailed in the
Table. cIMT was positively associated with interleukin-6 (RS  0.17, P 
.0001), fasting glucose (RS 0.20, P .0001), and insulin (RS 0.14, P
.0002) levels and inversely associated with adiponectin (RS  0.20, P 
.0001), CD40L (RS  .014, P  .0003), and high-density lipoprotein
cholesterol (RS  0.20, P  .0001) levels. cIMT was not associated with
endostatin, highly-selective C-reactive protein, soluble intercellular adhe-
sion molecule, total cholesterol, low-density lipoprotein cholesterol, or
triglycerides. Multiple regression analysis identified age (partial correlation
[RP]  0.23, P  .0001), female sex (RP  0.16, P  .0001), black race
(RP  0.13, P  .0009), body mass index (RP  0.08, P  .04), serum
glucose (RP 0.14, P .0002), high-density lipoprotein cholesterol (RP
0.08, P  .03), and interleukin 6 (RP  0.07, P  .05) were indepen-
dently associated with cIMT.
Conclusions:We identified several biomarkers that are positively (interleu-
kin-6,glucose, insulin)or inversely (adiponectin,CD40L,high-density lipoprotein)
associated with cIMT. Because increased cIMT predicts cardiovascular outcomes,
examination of these clinical markers in relation to future cardiovascular events is
Fig.
JOURNAL OF VASCULAR SURGERY
September 2012890 Abstracts
